Insulin aspart
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'> | <StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'> | ||
| - | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart] and [[Insulin]]. | + | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart Insulin aspart] and [[Insulin]]. |
<scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). | <scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). | ||
Current revision
| |||||||||||
